Supplements Curb Isotretinoin-Associated Triglyceride Increase

Share this content:
Supplements Curb Isotretinoin-Associated Triglyceride Increase
Supplements Curb Isotretinoin-Associated Triglyceride Increase

MONDAY, Jan. 19, 2015 (HealthDay News) -- For patients with preexisting hypertriglyceridemia, ω-3 fatty acid (ω-3FA) supplementation stabilizes the expected increase in triglycerides during isotretinoin therapy, according to research published in the January issue of JAMA Dermatology.

Sheila Krishna, M.D., from the Virginia Commonwealth University in Richmond, and colleagues recruited 39 patients with acne who were treated with isotretinoin for a median of 5.87 months. Nineteen of the participants reported voluntary consistent intake of ω-3FA supplementation, and 20 participants reported no use of supplements. The authors conducted a retrospective review to examine changes in triglyceride levels during isotretinoin treatment.

The researchers found that for participants with preexisting elevated triglyceride levels, those not using supplements had a greater increase in triglyceride levels during treatment than those patients using supplements. During treatment the mean increase was 49 percent in triglyceride levels for those not using supplements, compared with 13.91 percent for those using supplements (P = 0.04).

"Supplements of ω-3FA may be a useful adjunct to the management of lipid levels during isotretinoin therapy," the authors write. "A future prospective, randomized placebo-controlled trial using a standard dose and formulation of ω-3FA is required to confirm this hypothesis."

One author disclosed financial ties to the pharmaceutical and nutritional supplement industries.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »